Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Messing

Showing results (21-30 of 199) with videos related to

Pageof 20
Sort By:
The Journal of Urology|October 9, 2003
Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?Edward M Messing
The Journal of Urology|March 7, 2006
Bladder tumor markersEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|November 21, 2017
Bladder Sparing Therapy for BCG Failures - I - Intravesical ImmunotherapyEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
The BCG ShortageEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
BCG versus Cystectomy for High Risk, High Grade Non Muscle Invasive Bladder CancerEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Implementing a New Standard of CareEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
BCG in Immunocompromised Patients: Is it effective? Is it safe?Edward M Messing
Urology Practice|June 15, 2023
Editorial CommentaryEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Perioperative Blood Transfusions and Bladder Cancer OutcomesEdward M Messing
Nature Clinical Practice. Urology|March 7, 2008
Why should we increase public awareness of bladder cancer, and how can we do it?Edward M Messing
Pageof 20

Showing results (21-30 of 199) with videos related to

Sort By:
Pageof 20
The Journal of Urology|October 9, 2003
Re: Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?Edward M Messing
The Journal of Urology|March 7, 2006
Bladder tumor markersEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|November 21, 2017
Bladder Sparing Therapy for BCG Failures - I - Intravesical ImmunotherapyEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2017
The BCG ShortageEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
BCG versus Cystectomy for High Risk, High Grade Non Muscle Invasive Bladder CancerEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Implementing a New Standard of CareEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
BCG in Immunocompromised Patients: Is it effective? Is it safe?Edward M Messing
Urology Practice|June 15, 2023
Editorial CommentaryEdward M Messing
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Perioperative Blood Transfusions and Bladder Cancer OutcomesEdward M Messing
Nature Clinical Practice. Urology|March 7, 2008
Why should we increase public awareness of bladder cancer, and how can we do it?Edward M Messing
Pageof 20